• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4-disubstituted thiazoles

Recent Advances in the Study of 2-Methylthiazole-4-carbonitrile (CAS: 21917-76-0) in Chemical Biology and Pharmaceutical Research

The compound 2-Methylthiazole-4-carbonitrile (CAS: 21917-76-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by its thiazole core and nitrile functional group, serves as a crucial building block in the synthesis of various bioactive molecules. Recent studies have highlighted its potential as a key intermediate in the development of novel therapeutics targeting infectious diseases, cancer, and neurological disorders.

One of the most notable advancements in the study of 2-Methylthiazole-4-carbonitrile is its role in the synthesis of kinase inhibitors. Kinases are pivotal in cellular signaling pathways, and their dysregulation is often implicated in cancer and inflammatory diseases. Researchers have successfully utilized 2-Methylthiazole-4-carbonitrile as a scaffold to design potent and selective kinase inhibitors. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in inhibiting specific tyrosine kinases, showcasing its potential as a lead compound for anticancer drug development.

In addition to its applications in oncology, 2-Methylthiazole-4-carbonitrile has shown promise in antimicrobial research. A recent study in Bioorganic & Medicinal Chemistry Letters reported the synthesis of novel derivatives of this compound, which exhibited potent activity against multidrug-resistant bacterial strains. The study emphasized the importance of the nitrile group in enhancing the compounds' binding affinity to bacterial targets, thereby improving their therapeutic efficacy. These findings underscore the compound's potential in addressing the global challenge of antibiotic resistance.

Another exciting development is the exploration of 2-Methylthiazole-4-carbonitrile in neuropharmacology. Researchers have identified its derivatives as potential modulators of neurotransmitter receptors, which could lead to new treatments for neurological disorders such as epilepsy and Parkinson's disease. A 2022 study in ACS Chemical Neuroscience highlighted the compound's ability to cross the blood-brain barrier, a critical factor in the development of central nervous system (CNS) therapeutics. This property, combined with its structural versatility, makes it a valuable candidate for further investigation.

The synthetic versatility of 2-Methylthiazole-4-carbonitrile has also been a focal point of recent research. Advances in green chemistry have enabled more efficient and sustainable methods for its synthesis, reducing the environmental impact of pharmaceutical production. A 2023 publication in Green Chemistry detailed a novel catalytic approach that minimizes waste and improves yield, paving the way for scalable industrial applications. Such innovations are crucial for meeting the growing demand for this compound in both academic and industrial settings.

In conclusion, the recent studies on 2-Methylthiazole-4-carbonitrile (CAS: 21917-76-0) highlight its multifaceted role in drug discovery and development. From kinase inhibitors to antimicrobial agents and CNS therapeutics, this compound continues to demonstrate its potential as a cornerstone of modern medicinal chemistry. Future research should focus on optimizing its derivatives for clinical use and exploring new therapeutic applications, ensuring its continued relevance in the ever-evolving field of pharmaceutical sciences.

• 136777-23-6(Thiazole, dimethyl-)
• 302341-70-4(2-(aminomethyl)-4-Thiazolecarbonitrile)
• 100516-98-1(4-methyl-1,3-thiazole-2-carbonitrile)
• 454483-81-9(2-(Bromomethyl)thiazole-4-carbonitrile)
• 848555-20-4(2-(tert-Butyl)thiazole-4-carbonitrile)
• 541-58-2(2,4-Dimethylthiazole)
• 1452-15-9(4-Cyanothiazole)
• 848555-18-0(2-Isopropylthiazole-4-carbonitrile)
• 466686-77-1(2-formyl-1,3-thiazole-4-carbonitrile)
• 848555-19-1(4-THIAZOLECARBONITRILE, 2-(2-METHYLPROPYL)-)